Guardant Health’s consensus analyst price target has recently moved upward from $93.82 to $99.00, signaling increased confidence in the company's future. This upgrade comes amid a surge in positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback